Business Daily from THE HINDU group of publications
Friday, November 6, 2009
ePaper | Mobile/PDA Version | Audio | Blogs
News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Subscription

Group Sites

Update at 1130 hrs (IST)


Corporate
Aurobindo Pharma gets FDA nod for ‘Lamotrigine’

MUMBAI: Aurobindo Pharma has informed BSE that the company has received the final approval for Lamotrigine tablets 5mg and 25 mg from the US Food & Drug Administration.

Lamotrigine tablets are generic equivalent to Lamictal CD tablets of GlaxoSmithKline.

Aurobindo Pharma has a total of 107 ANDA (abbreviated new drug application) approvals from USFDA. — Our Bureau

Prev: Rupee up 20 p at 46.80/dollar
Next: Indo Amines record date for interim dividend

Business Line | NUS Index |

Related Topics
Alliances & Joint Ventures
Announcements
Auditing
Awards & Honours
Bonus Announcements
Company Law
Corporate Bonds
Corporate Disputes
Corporate Governance
Courts/Legal Issues
Diversification
Environment
Human Resources
Interview
IPOs
IPR
Management
Mergers & Acquisitions
New Projects
Open Offers
Outlook
Outsourcing
Overseas Borrowings
Overseas Investments
People
Performance
Preferential Allotments
Private Placement
Regulatory Bodies & Rulings
Research & Development
Restructuring
Rights Issue
Sick Units
Society & Development
Standards & Benchmarks
Taxation
Trade & Labour Unions
The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright copy; 2009, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line